{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:47:13Z","timestamp":1789836433329,"version":"4.0.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The aim of this study was to apply latent class analysis to identify underlying groupings of predictors, including drug classes and clinical predictors, co-occurring in older people at higher risk of medication-related harm.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>The Adverse Drug reactions in an Ageing PopulaTion cohort was used (N\u2009=\u2009798 patients aged \u226565\u00a0years admitted acutely to hospital). Seven drug classes; antithrombotic agents, diuretics, renin-angiotensin-aldosterone system, calcium channel blockers, beta-blocking agents, psychoanaleptics, non-steroidal anti-inflammatory drugs, and comorbidity, frailty and significant polypharmacy (10+ different drug classes) were included as potential predictors of medication-related harm. Medication-related harm outcomes included adverse drug reactions (ADR)-related hospital admissions, health-related quality of life, functional impairment and emergency department visits. Determination of the best number of latent classes was based on standard comparison of fit statistics. Univariate and multivariable logistic, linear and Poisson regression models were used to examine the associations between the latent groups and the medication-related harm outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A five class model was determined to fit best; (i) high-risk prescribing and polypharmacy group (N\u2009=\u2009245); (ii) low-risk group (n\u2009=\u2009138); (iii) high-risk prescribing only group (N\u2009=\u2009332); (iv) antihypertensive group (N\u2009=\u200918); and (v) psychoanaleptics and polypharmacy group (N\u2009=\u200965). Patients in both the high-risk prescribing and polypharmacy group (a.OR\u2009=\u20092.59, 95%CI\u2009=\u20091.51\u20134.44) and the high-risk prescribing only group (a.OR\u2009=\u20092.85, 95%CI\u2009=\u20091.57\u20135.20) were more likely to have an ADR-related hospital admission, with the high-risk prescribing and polypharmacy group also having statistically significant higher functional impairment (\u03b2\u2009=\u20091.21, 95% CI\u2009=\u20090.09, 2.33) compared to those in the low-risk group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Identifying distinct subgroups of older people based on their medications may lead to more targeted and tailored interventions to reduce potential medication-related harm.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afaf227","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T12:17:15Z","timestamp":1755778635000},"source":"Crossref","is-referenced-by-count":3,"title":["Identifying predictors of medication-related harm in older populations: a latent class analysis approach"],"prefix":"10.1093","volume":"54","author":[{"given":"Ross","family":"Brannigan","sequence":"first","affiliation":[{"name":"Royal College of Surgeons in Ireland, School of Population Health , Dublin, Leinster ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Frydenlund","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, School of Population Health , Dublin, Leinster ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Geriatric and Stroke Medicine, Royal College of Surgeons in Ireland , Dublin, Leinster ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-3625","authenticated-orcid":false,"given":"Frank","family":"Moriarty","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, School of Pharmacy and Biomolecular Sciences , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Wallace","sequence":"additional","affiliation":[{"name":"Department of General Practice, University College Cork School of Medicine , Cork ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Kirke","sequence":"additional","affiliation":[{"name":"National Quality and Patient Safety Directorate at Health Service Executive , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E","family":"Bennett","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, School of Population Health , Dublin, Leinster ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-5737","authenticated-orcid":false,"given":"Caitriona","family":"Cahir","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, School of Population Health , Dublin, Leinster ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"2025082108171388100_ref1","volume-title":"Global Patient Safety Action Plan 2021\u20132030: Towards Eliminating Avoidable Harm in Health Care","author":"WHO","year":"2021"},{"key":"2025082108171388100_ref2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a Clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann Intern Med"},{"key":"2025082108171388100_ref3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","article-title":"Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis","volume":"73","author":"Oscanoa","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2025082108171388100_ref4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ageing\/afz121","article-title":"Medication-related harm: a geriatric syndrome","volume":"49","author":"Stevenson","year":"2019","journal-title":"Age Ageing"},{"key":"2025082108171388100_ref5","article-title":"Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models","volume":"1581\u20131593","author":"Stevenson","year":"2014","journal-title":"Clin Interv Aging"},{"key":"2025082108171388100_ref6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2147\/CIA.S71178","article-title":"A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting","volume":"9","author":"Alhawassi","year":"2014","journal-title":"Clin Interv Aging"},{"key":"2025082108171388100_ref7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7861\/clinmedicine.16-5-481","article-title":"Adverse drug reactions","volume":"16","author":"Coleman","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"2025082108171388100_ref8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00228-024-03774-7","article-title":"Risk prediction models for adverse drug reactions and adverse drug events in older adults-a systematic review and meta-analysis","volume":"81","author":"Cosgrave","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"key":"2025082108171388100_ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020323","article-title":"Potentially inappropriate prescribing and potential prescribing omissions and their association with adverse drug reaction-related hospital admissions","volume":"13","author":"Brannigan","year":"2024","journal-title":"J Clin Med"},{"key":"2025082108171388100_ref10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1370\/afm.2373","article-title":"Potentially inappropriate prescribing among older persons: a meta-analysis of observational studies","volume":"17","author":"Liew","year":"2019","journal-title":"Ann Fam Med"},{"key":"2025082108171388100_ref11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1177\/1060028014552821","article-title":"Potentially inappropriate prescribing and vulnerability and hospitalization in older community-dwelling patients","volume":"48","author":"Cahir","year":"2014","journal-title":"Ann Pharmacother"},{"key":"2025082108171388100_ref12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/gerona\/glw140","article-title":"Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study","volume":"72","author":"Wallace","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025082108171388100_ref13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40266-018-0554-2","article-title":"International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action","volume":"35","author":"Mangin","year":"2018","journal-title":"Drugs Aging"},{"key":"2025082108171388100_ref14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ageing\/afy157","article-title":"Detection and prevention of adverse drug reactions in multi-morbid older patients","volume":"48","author":"Jennings","year":"2019","journal-title":"Age Ageing"},{"key":"2025082108171388100_ref15"},{"key":"2025082108171388100_ref16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/096228029600500205","article-title":"Latent class analysis in medical research","volume":"5","author":"Formann","year":"1996","journal-title":"Stat Methods Med Res"},{"key":"2025082108171388100_ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017322","article-title":"Adverse drug reactions in an ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients","volume":"7","author":"Cahir","year":"2017","journal-title":"BMJ Open"},{"key":"2025082108171388100_ref18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1029067","article-title":"Adverse drug reactions in an ageing PopulaTion (ADAPT) study: prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients","volume-title":"Frontiers in Pharmacology","author":"Cahir","year":"2023"},{"key":"2025082108171388100_ref19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00228-023-03552-x","article-title":"Costs associated with adverse drug reactions in an older population admitted to hospital: a prospective cohort study","volume":"79","author":"Bennett","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"2025082108171388100_ref20","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review","volume":"62","author":"Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"2025082108171388100_ref21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2025082108171388100_ref22","first-page":"224","article-title":"A brief risk-stratification tool to predict repeat emergency department visits and hospitalizations in older patients discharged from the emergency department","volume":"10","author":"Meldon","year":"2003","journal-title":"Acad Emerg Med"},{"key":"2025082108171388100_ref23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"2025082108171388100_ref24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-SD: a measure of health status from the EuroQol group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"2025082108171388100_ref25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s40273-018-0690-x","article-title":"Utility values for health states in Ireland: a value set for the EQ-5D-5L","volume":"36","author":"Hobbins","year":"2018","journal-title":"Pharmacoeconomics."},{"key":"2025082108171388100_ref26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jamda.2012.04.007","article-title":"Measurement properties of the Groningen frailty indicator in home-dwelling and institutionalized elderly people","volume":"13","author":"Peters","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"2025082108171388100_ref27","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/CCM.0000000000004710","article-title":"Practitioner's guide to latent class analysis: methodological considerations and common pitfalls","volume":"49","author":"Sinha","year":"2021","journal-title":"Crit Care Med"},{"key":"2025082108171388100_ref28"},{"key":"2025082108171388100_ref29","volume-title":"Stata Statistical Software: Release 19","author":"StataCorp.","year":"2025"},{"key":"2025082108171388100_ref30","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1038\/s41598-021-86331-x","article-title":"A multidimensional measure of polypharmacy for older adults using the health and retirement study","volume":"11","author":"Carr","year":"2021","journal-title":"Sci Rep"},{"key":"2025082108171388100_ref31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40266-023-01028-2","article-title":"Classifying polypharmacy according to pharmacotherapeutic and clinical risks in older adults: a latent class analysis in Quebec","volume":"40","author":"Gosselin","year":"2023","journal-title":"Canada Drugs & Aging"},{"key":"2025082108171388100_ref32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jclinepi.2022.05.008","article-title":"Part I: a friendly introduction to latent class analysis","volume":"147","author":"Aflaki","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"2025082108171388100_ref33","doi-asserted-by":"publisher","first-page":"102703","DOI":"10.1016\/j.eclinm.2024.102703","article-title":"Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts","volume":"74","author":"Krauth","year":"2024","journal-title":"eClinicalMedicine."},{"key":"2025082108171388100_ref34","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/jgs.18295","article-title":"The heterogeneity of the homebound: a latent class analysis of a national sample of homebound older adults","volume":"71","author":"Mather","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"2025082108171388100_ref35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s41999-024-01152-1","article-title":"Adverse drug reactions and events in an ageing PopulaTion risk prediction (ADAPTiP) tool: the development and validation of a model for predicting adverse drug reactions and events in older patients","volume":"16","author":"Frydenlund","year":"2025","journal-title":"Eur Geriatr Med"},{"key":"2025082108171388100_ref36","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","article-title":"Risk prediction models: II. External validation, model updating, and impact assessment","volume":"98","author":"Moons","year":"2012","journal-title":"Heart."},{"key":"2025082108171388100_ref37","first-page":"1","article-title":"Identifying high-risk groups for self-harm in adolescents using the Avon longitudinal study of parents and children (ALSPAC): a cross-cohort comparison latent class analysis study","volume":"5","author":"McEvoy","year":"2025","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2025082108171388100_ref38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jgs.15195","article-title":"Meta-analysis of interventions to reduce adverse drug reactions in older adults","volume":"66","author":"Gray","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2025082108171388100_ref39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","article-title":"Which drugs cause preventable admissions to hospital? A systematic review","volume":"63","author":"Howard","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"2025082108171388100_ref40","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.3399\/BJGP.2022.0181","article-title":"Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study","volume":"73","author":"Doherty","year":"2023","journal-title":"Br J Gen Pract"},{"key":"2025082108171388100_ref41","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/bcp.13590","article-title":"The relationship between frailty and polypharmacy in older people: a systematic review","volume":"84","author":"Guti\u00e9rrez-Valencia","year":"2018","journal-title":"Br J Clin Pharmacol"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/8\/afaf227\/64100782\/afaf227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/8\/afaf227\/64100782\/afaf227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T12:17:17Z","timestamp":1755778637000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afaf227\/8239078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaf227","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8,1]]},"article-number":"afaf227"}}